Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

2011470 citationsJournal Articlebronze Open Access

Authors

Heiner Wedemeyer · Medizinische Hochschule Hannover

Cihan Yurdaydın · Ankara University

George Ν. Dalekos · University Hospital of Larissa

Andreas Erhardt · Heinrich Heine University Düsseldorf

Yılmaz Çakaloğlu

Halil Değertekin · Ufuk University

Selım Gürel · Bursa Uludağ Üni̇versi̇tesi̇

Abstract

Treatment with peginterferon alfa-2a for 48 weeks, with or without adefovir, resulted in sustained HDV RNA clearance in about one quarter of patients with HDV infection. (Current Controlled Trials number, ISRCTN83587695.).

Topics & Keywords

Hepatitis C virus research Hepatitis B Virus Studies Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 364, Issue 4, pp. 322-331

DOI: 10.1056/nejmoa0912696

Field-Weighted Citation Impact: 18.83